|
|
 |
|
ARIA: Ariad Pharmaceuticals Inc - Stock News |
Enter Ticker:
|
|
| Nov 23, 2009 |
ARIAD to Present Data on Pan-BCR-ABL Inhibitor AP24534 at 51st American Society of Hematology Meeting |
| Nov 10, 2009 |
ARIAD to Present at the Lazard Capital Markets 6th Annual Healthcare Conference |
| Nov 09, 2009 |
Closing Update: Stocks Strike Fresh Year-Plus Highs |
| Nov 05, 2009 |
ARIAD Reports Third Quarter 2009 Development Progress and Financial Results |
| Nov 02, 2009 |
Ariad Pharmaceuticals Down 9.4% Since SmarTrend's Sell Recommendation |
| Nov 02, 2009 |
ARIAD's AP24534 Featured in Cancer Cell Publication as a Potential First-in-Class Pan BCR-ABL Inhibitor |
| Nov 02, 2009 |
BUYINS.NET: SSS, XNPT, EBS, ARIA, OPTV, BGFV Expected To Be Lower Leading Up To Next Earnings Releases |
| Oct 28, 2009 |
BiomedReports: News and FDA Updates for ARIAD (NASDAQ:ARIA), PolyMedix (OTC:PYMX), Ligand (NASDAQ:LGND) Metabasis (NASDAQ:MBRX) |
| Oct 27, 2009 |
ARIAD to Present at the Oppenheimer 20th Annual Healthcare Conference |
| Oct 22, 2009 |
ARIAD to Webcast Conference Call on Third Quarter 2009 Financial Results |
| Sep 21, 2009 |
ARIAD Announces Clinical Data from Phase 1 Study of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Bevacizumab |
| Sep 14, 2009 |
ARIAD Announces Result of First Interim Analysis of Phase 3 Succeed Trial of Oral Ridaforolimus, Its Investigational mTOR Inhibitor, in Metastatic Sarcomas |
| Sep 08, 2009 |
Ariad Pharmaceuticals (ARIA) Bullish Technical Alert - Trend Up 38.7% |
| Sep 02, 2009 |
ARIAD to Present at the Rodman & Renshaw Annual Healthcare Conference |
| Sep 01, 2009 |
Ariad Pharmaceuticals (ARIA) Bullish Technical Alert - Trend Up 35.3% |
| |
| ZACKS COMMENTARY FOR ARIA |
|
|
|
Sponsored Links 
0.04